Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
79 studies found for:    s1115
Show Display Options
Rank Status Study
1 Active, not recruiting Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy
Conditions: Pancreatic Acinar Cell Carcinoma;   Pancreatic Ductal Adenocarcinoma;   Recurrent Pancreatic Carcinoma;   Stage IV Pancreatic Cancer
Interventions: Drug: Akt Inhibitor MK2206;   Drug: Selumetinib;   Drug: Oxaliplatin;   Drug: Fluorouracil
2 Completed S9832: Effectiveness of Telephone Counseling By Breast Cancer Survivors on the Well-Being of Women With Recurrent Breast Cancer
Conditions: Breast Cancer;   Psychosocial Effects of Cancer and Its Treatment
Intervention: Procedure: psychosocial assessment and care
3 Completed
Has Results
Safety and Efficacy Evaluation Of Pregabalin (Lyrica) With Patients With Generalized Anxiety Disorder
Condition: Generalized Anxiety Disorder
Interventions: Drug: Pregabalin;   Drug: Lorazepam;   Drug: Placebo
4 Completed S0119: Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: gemcitabine hydrochloride;   Drug: irinotecan hydrochloride
5 Completed S0007 - Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
Condition: Head and Neck Cancer
Interventions: Drug: cisplatin;   Drug: fluorouracil;   Drug: paclitaxel
6 Completed
Has Results
S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: bicalutamide;   Drug: estramustine;   Drug: etoposide;   Drug: flutamide;   Drug: goserelin;   Drug: leuprolide;   Drug: nilutamide;   Drug: paclitaxel
7 Withdrawn S0227 Cisplatin With Either Paclitaxel or Gemcitabine in Recurrent, Persistent, or Metastatic Cervical Cancer
Condition: Cervical Cancer
Interventions: Drug: cisplatin;   Drug: gemcitabine hydrochloride;   Drug: paclitaxel
8 Completed A Trial Investigating the NN1250 Concentration-time Curve in Subjects With Various Degrees of Renal Impairment and in Subjects With Normal Renal Function
Conditions: Diabetes;   Healthy
Intervention: Drug: insulin degludec
9 Completed S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the Urothelium
Conditions: Bladder Cancer;   Urethral Cancer
Interventions: Drug: carboplatin;   Drug: cisplatin;   Drug: gemcitabine hydrochloride;   Drug: paclitaxel;   Procedure: neoadjuvant therapy;   Radiation: radiation therapy
10 Active, not recruiting ION US Post-Approval Study
Conditions: Atherosclerosis;   Coronary Artery Disease
Intervention: Device: ION™ Coronary Stent System
11 Active, not recruiting Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
Condition: Atherosclerosis
Interventions: Drug: Canakinumab;   Drug: Placebo
12 Completed Effect of Different Doses of SAR110894D on Cognition in Patients With Mild to Moderate Alzheimer's Disease on Donepezil
Condition: Dementia Alzheimer's Type
Interventions: Drug: SAR110894D;   Drug: placebo
13 Completed
Has Results
Safety and Tolerability of Vortioxetine (LuAA21004) - Open Label Extension Study
Condition: Depressive Disorder, Major
Intervention: Drug: Vortioxetine
14 Enrolling by invitation Human Menstrual Blood-derived Mesenchymal Stem Cells for Patients With Liver Cirrhosis
Conditions: Liver Cirrhosis;   Fibrosis;   Liver Disease;   Digestive System Disease
Interventions: Biological: conventional therapy plus MenSC transplantation;   Drug: Conventional therapy plus placebo treatment
15 Recruiting A Safety and Tolerability Study of Assisted- and Self-Administered Subcutaneous Herceptin (Trastuzumab) as Adjuvant Therapy in Patients With Early HER2-Positive Breast Cancer (SafeHer)
Condition: Breast Cancer
Intervention: Drug: trastuzumab [Herceptin]
16 Active, not recruiting A Study to Evaluate Safety and Efficacy of GSK1278863 in Non-Dialysis Dependent (NDD) Subjects With Anemia Associated With Chronic Kidney Diseases (CKD)
Condition: Anaemia
Interventions: Drug: GSK1278863;   Drug: rhEPO
17 Completed Comparison of Two Identical NN1250 Formulations in Healthy Volunteers
Conditions: Diabetes;   Healthy
Intervention: Drug: insulin degludec
18 Active, not recruiting Ponesimod in Patients With Relapsing-remitting Multiple Sclerosis -Extension Study
Condition: Relapsing-remitting Multiple Sclerosis
Intervention: Drug: Ponesimod
19 Recruiting A Study of Kadcyla (Trastuzumab Emtansine) in Patients With HER2 Positive Breast Cancer Who Have Received Prior Anti-HER2 And Chemotherapy-based Treatment
Condition: Breast Cancer
Intervention: Drug: Kadcyla (trastuzumab emtansine)
20 Completed ACT-128800 in Relapsing-remitting Multiple Sclerosis
Condition: Relapsing-remitting Multiple Sclerosis
Interventions: Drug: ACT-128800;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years